{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T17:40:50Z","timestamp":1781890850686,"version":"3.54.5"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Exploratory Research in Clinical and Social Pharmacy"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.rcsop.2025.100669","type":"journal-article","created":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:07:05Z","timestamp":1759554425000},"page":"100669","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Appropriateness of empiric antibiotic therapy for community-acquired pneumonia: A multicenter cross-sectional study"],"prefix":"10.1016","volume":"20","author":[{"given":"Deema","family":"Rahme","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hania Nakkash","family":"Chmaisse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascale","family":"Salameh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.rcsop.2025.100669_bb0005","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1080\/14760584.2023.2261785","article-title":"Clinical, economic, and humanistic burden of community acquired pneumonia in Europe: a systematic literature review","volume":"22","author":"Tsoumani","year":"2023","journal-title":"Expert Rev Vaccines"},{"issue":"2","key":"10.1016\/j.rcsop.2025.100669_bb0010","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00134-019-05519-y","article-title":"Challenges in severe community-acquired pneumonia: a point-of-view review","volume":"45","author":"Torres","year":"2019","journal-title":"Intensive Care Med"},{"issue":"4","key":"10.1016\/j.rcsop.2025.100669_bb0015","first-page":"177","article-title":"Community-acquired pneumonia in adults: what\u2019s new focusing on epidemiology, microorganisms and diagnosis?","volume":"40","author":"Tejada","year":"2018","journal-title":"J Clin Pract Res"},{"issue":"10","key":"10.1016\/j.rcsop.2025.100669_bb0020","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.3390\/vaccines10101650","article-title":"Pneumococcal disease in high-risk adults in Lebanon: expert opinion","volume":"10","author":"Bizri","year":"2022","journal-title":"Vaccines (Basel)"},{"issue":"10","key":"10.1016\/j.rcsop.2025.100669_bb0025","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1080\/14787210.2023.2257392","article-title":"Interventions to improve outcomes in community-acquired pneumonia","volume":"21","author":"Cilloniz","year":"2023","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.rcsop.2025.100669_bb0030","series-title":"Seminars in Respiratory and Critical Care Medicine","article-title":"Definition, epidemiology, and pathogenesis of severe community-acquired pneumonia","author":"Cavallazzi","year":"2024"},{"issue":"02","key":"10.1016\/j.rcsop.2025.100669_bb0035","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1055\/s-0044-1781426","article-title":"Long-term outcomes in severe community-acquired pneumonia","volume":"45","author":"Carella","year":"2024","journal-title":"Semin Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.rcsop.2025.100669_bb0040","first-page":"01","article-title":"The impact of adherence to community-acquired pneumonia (CAP) management guidelines on improving clinical outcomes in hospitalized patients","volume":"21","author":"Alnajjar","year":"2023","journal-title":"Pharm Pract"},{"key":"10.1016\/j.rcsop.2025.100669_bb0045","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.hrtlng.2024.01.010","article-title":"Socio-demographic and comorbid risk factors for poor prognosis in patients hospitalized with community-acquired bacterial pneumonia in southeastern US","volume":"65","author":"Idigo","year":"2024","journal-title":"Heart Lung"},{"issue":"S2","key":"10.1016\/j.rcsop.2025.100669_bb0050","doi-asserted-by":"crossref","DOI":"10.1017\/ash.2023.258","article-title":"Risk factors and outcomes associated with inappropriate empiric broad-spectrum antibiotic use in hospitalized patients with community-acquired pneumonia","volume":"3","author":"Gandhi","year":"2023","journal-title":"Antimicrob Stewardship Healthcare Epidemiol"},{"issue":"7","key":"10.1016\/j.rcsop.2025.100669_bb0055","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofae336","article-title":"Guideline-concordant therapy for community-acquired pneumonia in the hospitalized population: a systematic review and meta-analysis","volume":"11","author":"Seo","year":"2024","journal-title":"Open Forum Infect Dis"},{"issue":"1","key":"10.1016\/j.rcsop.2025.100669_bb0060","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1471-2334-14-61","article-title":"Clinical implications for patients treated inappropriately for community-acquired pneumonia in the emergency department","volume":"14","author":"Micek","year":"2014","journal-title":"BMC Infect Dis"},{"issue":"6","key":"10.1016\/j.rcsop.2025.100669_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2017.09.014","article-title":"Initial empiric antibiotic therapy for community-acquired pneumonia in Chinese hospitals","volume":"24","author":"Nie","year":"2018","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"10.1016\/j.rcsop.2025.100669_bb0070","first-page":"2765","article-title":"Appropriate antibiotic use for community-acquired pneumonia in inpatient settings and its impact on 30-days readmission and mortality rate","volume":"15","author":"Kamila","year":"2019","journal-title":"Indian J Forens Med Toxicol"},{"issue":"10","key":"10.1016\/j.rcsop.2025.100669_bb0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0258698","article-title":"Factors influencing inappropriate use of antibiotics: findings from a nationwide survey of the general public in Malaysia","volume":"16","author":"Wong","year":"2021","journal-title":"PloS One"},{"issue":"3","key":"10.1016\/j.rcsop.2025.100669_bb0080","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3390\/arm91030018","article-title":"Identify drug-resistant pathogens in patients with community-acquired pneumonia","volume":"91","author":"Amati","year":"2023","journal-title":"Adv Respir Med"},{"issue":"1","key":"10.1016\/j.rcsop.2025.100669_bb0085","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00057-2019","article-title":"Broad-spectrum antibiotic use and poor outcomes in community-onset pneumonia: a cohort study","volume":"54","author":"Webb","year":"2019","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.rcsop.2025.100669_bb0090","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.chest.2019.01.013","article-title":"Principles and practice of antibiotic stewardship in the ICU","volume":"156","author":"Pickens","year":"2019","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.rcsop.2025.100669_bb0095","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2217\/cer-2019-0151","article-title":"The 1-year economic burden of community-acquired pneumonia (CAP) initially managed in the outpatient setting in the USA","volume":"9","author":"Divino","year":"2020","journal-title":"J Comp Effect Res"},{"issue":"1","key":"10.1016\/j.rcsop.2025.100669_bb0100","doi-asserted-by":"crossref","DOI":"10.1186\/s41479-017-0042-1","article-title":"Economic burden of community-acquired pneumonia among elderly patients: a Japanese perspective","volume":"9","author":"Konomura","year":"2017","journal-title":"Pneumonia"},{"issue":"8","key":"10.1016\/j.rcsop.2025.100669_bb0105","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S2213-2600(13)70084-5","article-title":"Severity assessment scores to guide empirical use of antibiotics in community acquired pneumonia","volume":"1","author":"Singanayagam","year":"2013","journal-title":"Lancet Respir Med"},{"issue":"1","key":"10.1016\/j.rcsop.2025.100669_bb0110","first-page":"40","article-title":"The Lebanese Society for Infectious Diseases and Clinical Microbiology (LSIDCM) guidelines for adult community-acquired pneumonia (CAP) in Lebanon","volume":"62","author":"Moghnieh","year":"2014","journal-title":"J Med Libanais"},{"key":"10.1016\/j.rcsop.2025.100669_bb0115","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jgar.2022.12.005","article-title":"Physicians\u2019 attitudes, knowledge, and practices regarding antibiotic prescriptions","volume":"32","author":"Rahbi","year":"2023","journal-title":"J Glob Antimicrob Resist"},{"issue":"2","key":"10.1016\/j.rcsop.2025.100669_bb0120","doi-asserted-by":"crossref","DOI":"10.1093\/jacamr\/dlae064","article-title":"Antibiotic prescribing practices of medical doctors in a resource-limited setting and the influence of individual perceptions and stewardship support: a survey in three tertiary hospitals in Vietnam","volume":"6","author":"Vu","year":"2024","journal-title":"JAC-Antimicrob Resist"},{"key":"10.1016\/j.rcsop.2025.100669_bb0125","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ijid.2017.09.010","article-title":"Professional practice evaluation of emergency department prescriptions for community-acquired infections in Lebanon","volume":"64","author":"Fahs","year":"2017","journal-title":"Int J Infect Dis"},{"issue":"3","key":"10.1016\/j.rcsop.2025.100669_bb0130","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s10654-019-00494-6","article-title":"Principles of confounder selection","volume":"34","author":"Vanderweele","year":"2019","journal-title":"Eur J Epidemiol"},{"issue":"12","key":"10.1016\/j.rcsop.2025.100669_bb0135","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.3390\/antibiotics12121680","article-title":"Antibiotic guideline adherence at the emergency department: a descriptive study from a country with a restrictive antibiotic policy","volume":"12","author":"Cartuliares","year":"2023","journal-title":"Antibiotics"},{"issue":"1","key":"10.1016\/j.rcsop.2025.100669_bb0140","first-page":"44","article-title":"Causes of non-adherence to therapeutic guidelines in severe community-acquired pneumonia","volume":"27","author":"Gattarello","year":"2015","journal-title":"Rev Brasil Terap Intens"},{"issue":"7","key":"10.1016\/j.rcsop.2025.100669_bb0145","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/s11739-016-1445-3","article-title":"Adherence to guidelines for hospitalized community-acquired pneumonia over time and its impact on health outcomes and mortality","volume":"11","author":"Costantini","year":"2016","journal-title":"Intern Emerg Med"},{"issue":"1","key":"10.1016\/j.rcsop.2025.100669_bb0150","doi-asserted-by":"crossref","DOI":"10.1186\/s12890-022-02178-6","article-title":"Antimicrobial therapy of community-acquired pneumonia during stewardship efforts and a coronavirus pandemic: an observational study","volume":"22","author":"Waagsb\u00f8","year":"2022","journal-title":"BMC Pulm Med"},{"issue":"4","key":"10.1016\/j.rcsop.2025.100669_bb0155","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1007\/s11096-020-01218-7","article-title":"Trends in the consumption of antibiotics in the Lebanese community between 2004 and 2016","volume":"43","author":"Lahoud","year":"2021","journal-title":"Int J Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.rcsop.2025.100669_bb0160","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-022-07883-5","article-title":"First trend analysis of antifungals consumption in Lebanon using the World Health Organization collaborating center for drug statistics methodology","volume":"22","author":"Rahme","year":"2022","journal-title":"BMC Infect Dis"},{"issue":"1","key":"10.1016\/j.rcsop.2025.100669_bb0165","first-page":"27094","article-title":"Evaluation of antibiotic prescription in the Lebanese community: a pilot study","volume":"5","author":"Saleh","year":"2015","journal-title":"Infect Ecol Epidemiol"},{"key":"10.1016\/j.rcsop.2025.100669_bb0170","doi-asserted-by":"crossref","first-page":"7591","DOI":"10.2147\/IJGM.S333501","article-title":"Barriers to clinical practice guideline implementation among physicians: a physician survey","author":"Qumseya","year":"2021","journal-title":"Int J Gener Med"},{"issue":"1","key":"10.1016\/j.rcsop.2025.100669_bb0175","doi-asserted-by":"crossref","DOI":"10.1186\/s12913-019-3887-6","article-title":"Pharmaceutical marketing strategies\u2019 influence on physicians\u2019 prescribing pattern in Lebanon: ethics, gifts, and samples","volume":"19","author":"Khazzaka","year":"2019","journal-title":"BMC Health Serv Res"},{"issue":"6","key":"10.1016\/j.rcsop.2025.100669_bb0180","doi-asserted-by":"crossref","first-page":"409","DOI":"10.5455\/msm.2015.27.409-411","article-title":"Rural - urban differences in health care quality assessment","volume":"27","author":"Spasojevic","year":"2015","journal-title":"Mater Soc Med"},{"issue":"22","key":"10.1016\/j.rcsop.2025.100669_bb0185","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.3390\/healthcare11222975","article-title":"Compliance among registered nurses and doctors in critical care units: challenges affecting their adherence to standard precautions","volume":"11","author":"Elseesy","year":"2023","journal-title":"Healthcare"},{"key":"10.1016\/j.rcsop.2025.100669_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.metop.2022.100211","article-title":"Drug dose adjustment in patients with renal impairment attending a specialized referral hospital, Northwest Ethiopia","volume":"16","author":"Kassa Birarra","year":"2022","journal-title":"Metab Open"},{"issue":"3","key":"10.1016\/j.rcsop.2025.100669_bb0195","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jsps.2011.12.005","article-title":"Evaluation of applying drug dose adjustment by physicians in patients with renal impairment","volume":"20","author":"Alahdal","year":"2012","journal-title":"Saudi Pharm J"},{"key":"10.1016\/j.rcsop.2025.100669_bb0200","series-title":"4CPS-245 Inappropriate antibiotic dosage adjustments in patients with renal impairment: A cross-sectional analysis","author":"Aguado Paredes","year":"2022"},{"issue":"2","key":"10.1016\/j.rcsop.2025.100669_bb0205","article-title":"Improving antibiotic prescribing for UTIs in renal impairment","volume":"2","author":"Nicolson","year":"2020","journal-title":"Access Microbiol"},{"issue":"4","key":"10.1016\/j.rcsop.2025.100669_bb0210","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.arbr.2015.02.005","article-title":"Adherence with national guidelines in hospitalized patients with community-acquired pneumonia: results from the CAPO study in Venezuela","volume":"51","author":"Levy","year":"2015","journal-title":"Arch Bronconeumol (English Edition)"},{"issue":"4","key":"10.1016\/j.rcsop.2025.100669_bb0215","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1080\/14787210.2017.1274232","article-title":"Antibiotic stewardship in community-acquired pneumonia","volume":"15","author":"Viasus","year":"2017","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"4","key":"10.1016\/j.rcsop.2025.100669_bb0220","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.jinf.2016.07.001","article-title":"De-escalation versus continuation of empirical antimicrobial therapy in community-acquired pneumonia","volume":"73","author":"Yamana","year":"2016","journal-title":"J Infect"},{"issue":"2","key":"10.1016\/j.rcsop.2025.100669_bb0225","first-page":"49","article-title":"Community usage pattern of antibiotics within Lebanese population: a prospective study","volume":"5","author":"Khalifeh","year":"2017","journal-title":"Am J Pharmacol Sci"}],"container-title":["Exploratory Research in Clinical and Social Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667276625001106?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667276625001106?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T12:45:33Z","timestamp":1764765933000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667276625001106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":45,"alternative-id":["S2667276625001106"],"URL":"https:\/\/doi.org\/10.1016\/j.rcsop.2025.100669","relation":{},"ISSN":["2667-2766"],"issn-type":[{"value":"2667-2766","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Appropriateness of empiric antibiotic therapy for community-acquired pneumonia: A multicenter cross-sectional study","name":"articletitle","label":"Article Title"},{"value":"Exploratory Research in Clinical and Social Pharmacy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rcsop.2025.100669","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100669"}}